3rd Mar 2014 11:00
LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Monday it has launched the Cantab Research Suite, the latest offering in its cognitive testing platform for academic research.
Cambridge, which specialises in computerised neuropsychological tests, such as those enabling the early detection of dementia, said the CRS offers improved features including added support for 'touch' devices, a new layout for better use on smaller screens, such as tablets, a number of addtional languages, and improved graphics.
The AIM-listed company said the CRS is used to assess cognitive function in studies by academic facilities globally, and has been cited in more than 1,200 peer-reviewed publications.
Nick Kerton, Chief Executive Officer said, "We believe that it is imperative the Company is at the forefront of innovation and design, creating products that academic researchers need in the field. The launch of Cantab Research Suite does just that and launches Cantab onto more software platforms and territories."
Shares in Cambridge were untraded at 58.5 pence per share Monday.
By Alice Attwood; [email protected]; @AliceAtAlliance
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Cambridge Cog